• Alle
  • Pressrelease

Canopy Biosciences Acquires Zellkraftwerk GmbH

Simultaneously Closes Strategic Growth Investment from Ampersand Capital to Create a Leading Provider of Genomic and Cell and Tissue Analysis Products and Services ST. LOUIS — Canopy BiosciencesTM, LLC, a leading provider of gene editing and gene expression products and services, announced today that it has acquired Zellkraftwerk GmbH, a leader in multiplex cytometry. Leveraging […]

Contact Us

Please tell us how we can help you.

Nicht lesbar? Text ändern. captcha txt

Beginnen Sie mit der Eingabe und drücken Sie Enter, um zu suchen